Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis

NCT01342250 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cirrhosis

Interventions

BIOLOGICAL: conventional therapy plus low dose hUC-MSCs treatment
BIOLOGICAL: conventional therapy plus medium dose hUC-MSCs treatment
BIOLOGICAL: conventional therapy plus high dose hUC-MSCs treatment

Sponsor

Shenzhen Beike Bio-Technology Co., Ltd.

Collaborators

[object Object]